Skip to Content

Orkambi Side Effects

Generic Name: ivacaftor / lumacaftor

Note: This page contains side effects data for the generic drug ivacaftor / lumacaftor. It is possible that some of the dosage forms included below may not apply to the brand name Orkambi.

In Summary

Common side effects of Orkambi include: upper respiratory tract infection, dyspnea, chest discomfort, nausea, and skin rash. Other side effects include: influenza, and flatulence. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to ivacaftor / lumacaftor: oral tablet

As well as its needed effects, ivacaftor / lumacaftor may cause unwanted side effects that require medical attention.

Major Side Effects

If any of the following side effects occur while taking ivacaftor / lumacaftor, check with your doctor immediately:

More common:
  • Difficult or labored breathing
  • tightness in the chest
Incidence not known:
  • Blurred vision
  • dark urine
  • dizziness
  • headache
  • loss of appetite
  • nausea and vomiting
  • nervousness
  • pain or discomfort in upper right stomach area
  • pounding in the ears
  • slow or fast heartbeat
  • unusual tiredness
  • yellow eyes or skin

Minor Side Effects

Some ivacaftor / lumacaftor side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

More common:
  • Absent, missed, or irregular menstrual periods
  • bloated
  • body aches or pain
  • chills
  • cough
  • cramps
  • diarrhea
  • ear congestion
  • excess air or gas in the stomach or intestines
  • fever
  • full feeling
  • heavy bleeding
  • longer or heavier menstrual periods
  • loss of voice
  • muscle aches
  • passing gas
  • rash
  • sneezing
  • sore throat
  • stopping of menstrual bleeding
  • stuffy or runny nose
  • unusual weakness

For Healthcare Professionals

Applies to ivacaftor / lumacaftor: oral tablet

General

The most frequently reported side effects were dyspnea, nasopharyngitis, nausea, diarrhea, upper respiratory tract infection, fatigue, respiration abnormal, blood creatine phosphokinase increased, rash, flatulence, rhinorrhea, and influenza.[Ref]

Respiratory

Very common (10% or more): Infective pulmonary exacerbation of cystic fibrosis (37.5%), cough (30.5%), sputum increased (14.8 %), dyspnea (up to 14%), hemoptysis (13.8%), nasopharyngitis (up to 13%), upper respiratory tract infection (up to 10%)
Common (1% to 10%): Rhinitis, pharyngeal erythema, sinus congestion, respiration abnormal, rhinorrhea, nasal congestion

Ivacaftor:
Very common (10% or more): Nasopharyngitis, nasal congestion
Common (1% to 10%): Sinus congestion, pharyngeal erythema[Ref]

Gastrointestinal

Very common (10% or more): Nausea (up to 13%), diarrhea (up to 12%), abdominal pain
Common (1% to 10%): Flatulence, oropharyngeal pain, vomiting

Ivacaftor:
Very common (10% or more): Abdominal pain[Ref]

Dermatologic

Common (1% to 10%): Rash[Ref]

Nervous system

Very common (10% or more): Headache (up to 15.7%), dizziness

Ivacaftor:
Very common (10% or more): Dizziness, headache[Ref]

Other

Very common (10% or more): Bacteria in sputum
Common (1% to 10%): Blood creatine phosphokinase increased, fatigue, influenza, ear discomfort, ear pain, tinnitus, tympanic membrane hyperemia, vestibular disorder, chest discomfort
Uncommon (0.1% to 1%): Ear congestion

Ivacaftor:
Very common (10% or more): Bacteria in sputum
Common (1% to 10%): Ear discomfort, ear pain, tinnitus, tympanic membrane hyperemia, vestibular disorder
Uncommon (0.1% to 1%): Ear congestion[Ref]

Endocrine

Very common (10% or more): Breast mass
Uncommon (0.1% to 1%): Breast inflammation, gynecomastia, nipple disorder, nipple pain

Ivacaftor:
Common (1% to 10%): Breast mass
Uncommon (0.1% to 1%): Breast inflammation, gynecomastia, nipple disorder, nipple pain[Ref]

Cardiovascular

Common (1% to 10%): Blood pressure increased/hypertension[Ref]

Hepatic

Common (1% to 10%): AST increased, ALT increased
Uncommon (0.1% to 1%): Hepatic encephalopathy, cholestatic hepatitis
Frequency not reported: Total bilirubin increased[Ref]

Genitourinary

Common (1% to 10%): Menstruation abnormal/irregular, dysmenorrhea, metrorrhagia, amenorrhea, menorrhagia
Uncommon (0.1% to 1%): Oligomenorrhea, polymenorrhea[Ref]

Ocular

Frequency not reported: Non-congenital lens opacities[Ref]

References

1. "Product Information. Orkambi (ivacaftor-lumacaftor)." Vertex Pharmaceuticals, Cambridge, MA.

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

It is possible that some side effects of Orkambi may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide